Q2 STOCKS TO BUY

Cantor Fitzgerald Thinks This Pharma Stock Could Double

The analyst isn't concerned about UBX's trek to record lows

Digital Content Manager
Mar 7, 2019 at 12:55 PM
facebook X logo linkedin


The shares of Unity Biotechnology, Inc. (NASDAQ:UBX) suffered an 11.2% drop yesterday -- and touched a record low of $9.05 -- after poorly received fourth-quarter earnings. Despite all this, Cantor Fitzgerald last night initiated coverage of UBX with an "overweight" rating and a price target of $21 -- more than double the stock's current perch. The analyst waxed optimistic on Unity's "portfolio with multiple blockbusters," citing an increasing market for the company's age-related disease treatments. 

Cantor Fitzgerald is in good company, with three "buy" or better ratings and not a single "sell" for UBX. Plus, the analyst's $21 price target is still lower than the consensus 12-month target of $25.40 -- a roughly 173% premium to current levels. 

The stock was trading around $17 -- its initial public offering (IPO) price -- to start the year, but is down more than 42% year-to-date, amid pressure from its 20-day moving average. However, UBX today is up 2.4% at $9.30. 

UBX Chart March 7

Should Unity Biotechnology extend its bounce from new-low territory, a short squeeze could propel the stock higher. Currently, the 5.16 million UBX shares sold short represent a whopping 20.3% of the stock's available float. It would take over a month to buy back all these pessimistic positions, at the equity's average daily trading volume.
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter